Evicenter
MarkdownMedical informationP&T meetings
VK2735

Chronic weight management

Last updated
184 sources

Product information and disease descriptionProduct descriptionProduct informationPharmacology

Pharmacodynamics

11 evidence topics · 6 sources

Subcutaneous formulation: fasting glucose, HbA1c, and blood pressure at week 13 in the phase 2 trial
Subcutaneous formulation: weight loss persisting after the last dose in the phase 2 trial
Gastric emptying, energy intake, and body composition in humans

No evidence found.